We describe a case of microscopic polyangiitis manifested as pleuritis confirmed by thoracoscopic biopsy. An 80-year-old man presented with a three-day history of shortness of breath and cough. Chest radiography revealed patchy opacities in the lower fields of the bilateral lung and right-sided pleural effusion. Thoracentesis revealed lymphocytic pleural exudates. Thoracoscopic biopsy specimens were compatible with fibrotic pleuritis. He developed rapidly progressive glomerulonephritis with elevated myeloperoxidase anti-neutrophil cytoplasmic antibody titer in blood and pleural effusion. Although the patient was resistant to two weekly courses of pulse steroid therapy, he was successfully treated with a five-day course of intravenous immunoglobulin.
Introduction
Microscopic polyangiitis (MPA) is classified as a necrotizing smallsized-vessel vasculitis that primarily affects the kidneys and lungs [1] . MPA has a fatality rate of 20-54% at five years after diagnosis and causes substantial long-term morbidity in survivors [2] . Common lung involvement of MPA includes alveolar hemorrhage [3] , interstitial pneumonia [4] and pulmonary nodules and/or masses (single or multiple) that can cavitate [5] . The manifestations of MPA presented with pleuritis are rare [6] [7] [8] [9] . In addition, no reports have described thoracoscopic evaluation in patients with MPA accompanied by pleuritis. We report a case of MPA manifested as pleuritis confirmed by thoracoscopic biopsy.
Case Report
An 80-year-old man presented to a hospital with a three-day history of shortness of breath and cough. Chest radiography revealed patchy opacities in the lower fields of the bilateral lung and right-sided pleural effusion. He developed high fever on admission and was diagnosed with pneumonia. Intravenous sulbactam/ampicillin (4.5 g/day) followed by flomoxef (3 g/day) were administered. On day six, however, his symptoms worsened, and an increased pleural effusion was observed from a follow-up chest X-ray even after discontinuing all medications except for antibiotics. Antibiotics were changed to tazobactam/ piperacillin (13.5 g/day). On day 16, without any relief of his symptom and bilateral pleural effusion, he was referred to our hospital.
At 69 years old, he was diagnosed with hypertension and ischemic stroke. At 73 years old, he was diagnosed with epilepsy and bladder cancer, for which he underwent a transurethral resection of bladder tumor. He was prescribed with diazepam (6 mg/day), carbamazepine (800 mg/day), phenobarbital (30 mg/day), clobazam (5 mg/day), lamotrigine (25 mg/day), aspirin dialuminate (81 mg/day), amlodipine besilate (5 mg/day), etizolam (0.5 mg/day) and flunitrazepam (1 mg/day). He has a history of smoking (40 sticks per day) and was a plumber for over 50 years where he might have been frequently exposed to asbestos. He had a weight of 46.4 kg, height of 154.1 cm with a body mass index of 19.5. His temperature was 36.2 °C, heart rate was 81 beats/min, blood pressure was 127/57 mmHg, respiratory rate was 16 breaths/min and oxygen saturation was 99% while breathing 1 L/min of oxygen via a nasal cannula. Cardiac examination showed normal S1 and S2 sounds. Late-inspiratory fine crackles were heard in the lower fields of both the lungs. The abdomen was soft and non-tender. There was no skin lesion. Mild pitting edema was observed from the knees to the feet. The results of a neurologic examination were unremarkable. Laboratory findings obtained on admission are shown in Table 1 . The patient had normocytic anemia with a hemoglobin level of 9.9 g/dL and a mean corpuscular volume 100 fL. White blood cell count was slightly elevated at 10,780 cells/mm 3 with 78.1% neutrophils. C-reactive protein level was markedly elevated to 17.1mg/dL. Urinalysis revealed a red blood cell count of 30-49/high-power field and mild proteinuria. Chest radiography on admission revealed right-sided pleural effusion and patchy opacities in the lower fields of the left lung ( Figure 1 ). Computed tomography (CT) of the chest revealed ground-glass opacity, interlobular septal thickening and traction bronchiectasis at both the lower lobes with pleural effusion more predominant in the right lung 
To investigate the possibility of tuberculous pleural effusion and benign asbestos pleuritis malignant pleural mesothelioma, pleural biopsies were taken from the right parietal pleura using medical thoracoscopy. Thoracoscopic evaluation revealed inflamed and white, thickened appearance of the parietal and visceral pleuras with marked fibrinous network. Biopsy specimens demonstrated fibrotic change of the pleura with fibrin formation, compatible with fibrotic pleuritis (Figure 3 ). Although thoracentesis was performed, pleural effusion recurred. There was an elevation of serum creatinine level (4.42 mg/dL) with the onset of proteinuria (3.3 g/day) on hospital day 34. Myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA) was markedly elevated (680 U/mL), whereas proteinase-3 (PR-3)-ANCA, rheumatoid factor (RF) and antinuclear antibody (ANA) were within the normal limit (<10 U/mL). The level of MPO-ANCA in the pleural effusion was also elevated (1080 U/mL). Taken together with interstitial change of the lungs, the findings were compatible with those of rapidly progressive glomerulonephritis (RPGN) caused by MPA. His renal function and urinary findings deteriorated in spite of the two weekly courses of pulse steroid therapy with methylprednisolone at 500 mg/day for three days. We suspended the use of cyclophosphamide therapy because of the main concern for opportunistic infection. Therefore, we administered intravenous immunoglobulin (IVIg) (400 mg/kg/day) for five days, which resulted in decreased levels of both renal function and CRP, MPO-ANCA with a resolution of pleural fluid. The level of MPO-ANCA in than the left lung (Figure 2 ). Sputum smear with Gram staining and culture yielded no significant microbes. Thoracentesis revealed that the effusion had a yellow cloudy appearance with exudative features (pH 7.5; specific gravity 1.033; total protein 3.5 g/dL; glucose 116 mg/dL; lactate dehydrogenase 274 IU/L; adenosine deaminase 32 IU/L) and was rich in lymphocytes. No bacteria, fungi, or acid-fast bacilli were cultured, obviating the possibility of infection. Two hundred mL of fluid was removed. pime pime pime pime p pi im me e EDITRICE Case Report the Japanese Ministry of Health and Welfare [10] , that is, the presence of organ manifestations of the kidneys and lungs, and high serum levels of MPO-ANCA. Among the organ manifestation of MPA, kidney involvement is identified in 78-100% of MPA cases, whereas lung involvement occurs in 7-61% of MPA cases [6] [7] [8] [9] . Both organs are affected in 7-59% of MPA cases [6, 7] . According to a report from the French Vasculitis Study Group, in which 85 patients with MPA were evaluated, only two (5.9%) developed pleuritis [9] . Gaudin et al. reviewed 19 cases with MPA, in which only one patient had fibrinous pleuritis accompanied by interstitial fibrosis [11] . These reviews lack a precise description of pleural effusion. Nevertheless in rare cases, pleuritis has been reported as the only pulmonary manifestation in some cases of MPA [12, 13] , where exudates with a predominance of lymphocytes were confirmed by pleural fluid analysis. A report showed that the level of MPO-ANCA in pleural effusion was markedly elevated as that in serum [12] . Pleuritis antedated the appearance of RPGN in the report. In the present case, lymphocytic pleural exudates also presented with a high titer of MPO-ANCA which preceded the appearance of RPGN. Although no report has validated the utility of the measurement of MPO-ANCA in pleural effusion in cases of suspected MPA, a higher titer of MPO-ANCA in pleural effusion might suggest the predominant inflammation on the pleural surface, which was demonstrated in the thoracoscopic evaluation in our case. The present case revealed thoracoscopic findings which were not previously reported. Thoracoscopic evaluation is useful in the assessment of unexplained pleural exudates as it has an excellent diagnostic sensitivity and specificity (90-95% and 100%, respectively) [14] . To date, only one case report of MPA with pleuritis has described a closed pleural biopsy finding, which yielded the pathological diagnosis of nonspecific pleuritis [12] . Our pathological findings were compatible with the diagnosis.
Nonspecific pleuritis entails several possible alternative explanations. No vasculitis was found in the pleura. However, we diagnosed MPA-related pleuritis based on the elevated MPO-ANCA titer in pleural effusion. The resolution of pleural effusion was in accordance with the decrease in serum MPO-ANCA titer during the course of treatment for MPA. A report showed that 92% of patients with a nonspecific pleuritis pime pime pime pime p pi im me e EDITRICE the pleural effusion was also decreased (22 U/mL). After prednisolone was tapered, we started azathioprine at 25 mg/day. However, as the patient developed agranulocytosis, azathioprine was discontinued. We continued with only prednisolone to maintain the remission of the disease. The patient was discharged without any major complications except renal insufficiency. The patient's clinical course is summarized in Figure 4 .
Discussion
In this case report, we described a case of MPA manifested as pleuritis confirmed by thoracoscopic biopsy. The present case was finally classified as definite MPA based on the diagnostic criteria proposed by o n l y after thoracoscopy followed a benign course [15] . Hence, it is important to exclude malignancy such as malignant mesothelioma, with thoracoscopic visualization potentially playing a role in the diagnosis. In spite of deteriorating kidney function after pulse steroid therapy, we successfully treated the patient with IVIg. A randomized study suggested that azathioprine or pulse cyclophosphamide therapy was effective for treating corticosteroid-resistant disease [16] . However, repeated cycles of immunosuppressive therapy are associated with bone marrow suppression, myelodysplasia and infection, especially among the elderly as in the present case. IVIg has been shown to be effective in the treatment of relapses of MPA in a multicenter prospective openlabel trial [17] . In addition to the immunosuppressive effects of glucocorticoids [18] , IVIg provide immunoregulatory effects involving blockage of receptors for the Fc part of the IgG molecule (FcR) on macrophages and effector cells, attenuation of complement-mediated damage, control of autoreactive B cells and neutralization of active autoantibodies [19] . These effects may reflect the pathogenesis of MPA where ANCA interacts with FcR which are present in the neutrophils. On a similar note the alternative pathway of complement activation, TCell and B-cell are activated in MPA [20] .
In unexplained pleuritis, MPA must be considered even before the development of RPGN. Especially in cases with lymphocytic pleural exudates, thoracoscopic biopsy is useful as a diagnostic aid. Early diagnosis, including MPO-ANCA testing, prompts appropriate treatment before the occurrence of serious and potentially life-threatening complications. 
